Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Shares Outstanding (2014 - 2026)

Mesoblast's (MEOBF) quarterly Shares Outstanding (Entity) came in at $129.5 million in Q2 2026, up 1.16% year-over-year from $128.0 million in Q2 2025, and up 1.16% quarter-over-quarter from $128.0 million in Q2 2025.

Analysis

Mesoblast (MEOBF) Shares Outstanding (2014 - 2026) Analysis & Trends

Mesoblast has disclosed Shares Outstanding (Entity) across 13 years of filings, most recently posting $129.5 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) rose 1.16% year-over-year to $129.5 million; the TTM figure through Jun 2026 stood at $129.5 million (up 1.16% YoY), while the FY2026 annual figure was $129.5 million, up 1.16% from the prior year.
  • Shares Outstanding (Entity) came in at $129.5 million for Q2 2026 at Mesoblast, up from $128.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $129.5 million in Q2 2026 to a low of $65.0 million in Q2 2022.
  • Average Shares Outstanding (Entity) over 5 years is $103.6 million, with a median of $114.2 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Entity) climbed 0.27% in 2022 and surged 40.23% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $65.0 million in 2022, then climbed by 25.17% to $81.4 million in 2023, then soared by 40.23% to $114.2 million in 2024, then climbed by 12.1% to $128.0 million in 2025, then grew by 1.16% to $129.5 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $129.5 million in Q2 2026, $128.0 million in Q2 2025, and $114.2 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Krystal Biotech 10.27 Bn 9.42 Bn 112.79 Mn 29.53 Mn
2 CRISPR Therapeutics AG 5.20 Bn 5.20 Bn - 96.51 Mn
3 Iovance Biotherapeutics 3.78 Bn 3.49 Bn 55.72 Mn 450.19 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 184.32 Mn
5 uniQure 3.06 Bn 3.06 Bn 5.49 Mn 66.24 Mn
6 Beam Therapeutics 2.68 Bn 2.68 Bn - 104.33 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 356.89 Mn
8 Sarepta Therapeutics 2.35 Bn 1.55 Bn 251.87 Mn 105.43 Mn
9 Vericel 2.00 Bn 1.83 Bn 56.40 Mn 51.08 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - 129.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.49 Mn
Dec 31, 2025 120.78 Mn
Jun 30, 2025 120.78 Mn
Dec 31, 2024 98.67 Mn
Jun 30, 2024 98.67 Mn
Dec 31, 2023 73.90 Mn
Jun 30, 2023 73.90 Mn
Mar 31, 2023 64.89 Mn
Dec 31, 2022 64.89 Mn
Sep 30, 2022 64.89 Mn
Jun 30, 2022 64.89 Mn
Mar 31, 2022 60.51 Mn
Dec 31, 2021 60.51 Mn
Sep 30, 2021 60.51 Mn
Jun 30, 2021 60.51 Mn
Mar 31, 2021 52.88 Mn
Dec 31, 2020 52.88 Mn
Sep 30, 2020 52.88 Mn
Jun 30, 2020 52.88 Mn
Mar 31, 2020 49.44 Mn